T CELL LYMPHOBLASTIC LYMPHOMA
Clinical trials for T CELL LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T CELL LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for T CELL LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on tough T-Cell cancers
Disease control Recruiting nowThis early-phase trial is testing a new type of immunotherapy called CAR T cells, made from a patient's own blood cells, to treat T-cell acute lymphoblastic leukemia and lymphoma that has relapsed or not responded to standard treatments. The CAR T cells are designed to target a p…
Matched conditions: T CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
Engineered immune cells take on tough T-Cell cancers
Disease control Recruiting nowThis study tests a new treatment called CD7 CAR T-cell therapy for people with T-cell cancers that have come back or not responded to standard treatments. The therapy uses a patient's own immune cells or cells from a donor, which are modified to find and attack cancer cells. The …
Matched conditions: T CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 17, 2026 12:07 UTC
-
New hope for tough blood cancers: drug combo trial opens
Disease control Recruiting nowThis study is for adults with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma that has come back or not responded to treatment. Researchers are adding a new drug, capivasertib, to a standard chemotherapy and venetoclax regimen to see if it is safe and works better. T…
Matched conditions: T CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
Promising drug cocktail targets tough blood cancers in kids
Disease control Recruiting nowThis study tests whether a combination of three drugs—calaspargase pegol-mknl, decitabine, and venetoclax—can help control relapsed or treatment-resistant T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LLy) in patients aged 1 month to 21 years. T…
Matched conditions: T CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
New trial aims to boost survival in kids with rare lymphoma
Disease control Recruiting nowThis study compares two different ways of giving methotrexate (a chemotherapy drug) to children and teens newly diagnosed with T-cell lymphoblastic lymphoma, a rare cancer of the immune system. About 200 participants will be randomly assigned to one of two treatment plans to see …
Matched conditions: T CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC